Dr. Khashayar Mohebali, MD

Dr. Mohebali practices at Khashayar Mohebali MD a Medical Corporation in Novato, California.

Dr. Mohebali's NPI, 1437331360, was assigned on December 3, 2007. Dr. Mohebali graduated from Ohio State College of Medicine in 2004. Dr. Mohebali's California license number on file is A94434.

Dr. Mohebali's primary practice is Khashayar Mohebali MD a Medical Corporation, at 4 Hamilton Lndg, Novato, CA 94949 in Marin County. The practice phone is (415) 927-7660.

Dr. Mohebali's primary practice is Khashayar Mohebali MD a Medical Corporation in Novato, California. Dr. Mohebali is also affiliated with MarinHealth Medical Center. The medical group on file is Mohebali Plastic Surgery. Dmand AI also links Dr. Mohebali to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mohebali practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Mohebali's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Mohebali is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Mohebali has a license on file in California.

Dmand AI lists breast reconstruction, breast surgery and cancerous skin growth removal among the conditions Dr. Mohebali treats.

CMS data shows 43 Medicare services from Dr. Mohebali across 2 procedure codes in 2024, all of them office visits, for 53 Medicare patients. Medicare paid $3,990 for them. Every service was in an office.

CMS counts 53 Medicare patients who saw Dr. Mohebali in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have cancer, and 64% have high cholesterol. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mohebali's median patient age at 58, with 95% women.

In 2024, Dr. Mohebali wrote 80 Medicare Part D claims for 34 patients. 84% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $391 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.

Dr. Mohebali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 30 procedures of mastectomy by Dr. Mohebali, more than 86% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Mohebali. The most frequent topics are Tissue Expansion Devices, Breast Implants and Breast Neoplasms. Dr. Mohebali has published most often in Plast Reconstr Surg. Dr. Mohebali's most frequent co-authors are James Ziegler Appel, MD, Jeffrey Alan Ascherman, MD and Yoon Sun Chun, MD.

Dmand AI links Dr. Mohebali to 2 clinical trials. Conditions studied include Breast Neoplasms and Breast Diseases. AirXpanders, Inc. sponsors the most, 2.

CMS Open Payments shows 298 general payments to Dr. Mohebali from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. Mentor Worldwide LLC paid the most, $50,799. It also lists 1 research payment totaling $120 in 2021.

Dr. Mohebali graduated from Ohio State College of Medicine in 2004.

Dr. Mohebali is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.